"Integrating the Patient's Perspective into Device Evaluation Trials," Value In Health, Vol. 9, Issue 6: 394 2006 Nov-Dec.
"Allergic Rhinitis: A Potential Cause of Increased Asthma Medication Use, Costs, and Morbidity," Journal of Asthma, Vol. 41, No. 1, pp. 117-126 (Feb 2004)
"A Proactive Approach to Reimbursement in the Era of Drug-Eluting Stents," Journal of Cardiovascular Management, Vol. 13, No. 5, pp. 32-33 (Sep/Oct 2002)
"Cost-Effectiveness Results from the US Carvedilol Heart Failure Trials Program," The Annals of Pharmacotherapy, Vol. 35, No. 7, pp. 846-851 (Jul/Aug 2001)
“Influence of Carvedilol on Hospitalizations in Heart Failure: Incidence, Resource Utilization and Costs. U.S. Carvedilol Heart Failure Study Group,” Journal of the American College of Cardiology, Vol. 37, No. 6, pp. 1692-9 (May 2001)
“Antimicrobial Treatment Patterns, Resource Utilization, and Charges Associated with Acute Sinusitis in Asthma Patients,” American Journal of Health-System Pharmacy, Vol. 57, No. 9, pp. 875-881 (May 2000)
“Cost Effectiveness of Carvedilol for Heart Failure,” Journal of the American College of Cardiology, Vol. 83, No. 6, pp. 890-896 (Mar 1999)
“Cost-Effectiveness of Enoxaparin vs Low-Dose Warfarin in the Prevention of Deep-Vein Thrombosis after Total Hip Replacement Surgery,” Archives of Internal Medicine, Vol. 155, No. 7, pp. 757-764 (Apr 1995)
“Prevention of Deep-Vein Thrombosis Following Total Hip Replacement Surgery with Enoxaparin vs Unfractionated Heparin: A Pharmacoeconomic Evaluation, “ The Annals of Pharmacotherapy, Vol. 28, No. 2, pp. 271-275 (Feb 1994)
“Economic Evaluation of Oral Ofloxacin vs Standard Parenteral Therapy in the Treatment of Pneumonia,” Pharmacoeconomics, Vol. 2, No. 2, pp. 171-177 (Aug 1992)
“Transfusion Therapy: Associated Risks and Alternative Approaches,” ANNA Journal, Vol. 17, No. 6, pp. 457-464 (Dec 1990)
“Effect of Long-Term Epoetin Beta Therapy on the Quality of Life of Hemodialysis Patients, “ ASAIO Journal, Vol. 36, No. 3, pp. 157-160 (Jul 1990)
Hernandez J, Clark MA, Richner R, Wells S, Braid MJ, Moran D. “Lessons on Payment for New Medical Technologies: Analysis of Hospital Billing for Medical Devices under Medicare’s Hospital Outpatient Prospective Payment System,” The 5th International Conference on the Scientific Basis of Health Services, Washington, DC (Sep 2003)
Halpern M, Richner R, de Lissovoy G, Togias A. “Impact of Allergic Rhinitis on Overall Airway Disease, Medical Claims and Costs Among U.S. Patients with Asthma,” The European Respiratory Society Annual Congress, Berlin, Germany (Sep 1997)
Huse D, Richner R, Hartz S, Weiss S. “A Novel Approach to Assessing Asthma Costs in Managed Care Plans: The Asthma Outcomes Registry,” Association of Outcomes Research and Pharmacoeconomics (Jun 1997)
Klaus D, Huse D, Hartz S, Richner R, Kuriyama N, Weiss S. “The Prevalence of Sinusitis and Nasal Polyps Among Patients with Asthma in the Asthma Outcomes Registry,” American Academy of Allergy, Asthma and Immunology, Philadelphia, PA (Jun 1997)
Halpern M, Richner R, Togias A, Guo C, de Lissovoy G. “Allergic Rhinitus Influences Asthma Costs: A Database Evaluation,” International Society of Technology Assessment in Health Care 13th International Meeting, Barcelona, Spain (May 1997)
Huse D, Klause D, Piercey G, Kuriyama N, Weiss S, Richner R. “Patients Use of Asthma Drugs Does Not Conform to Expert Guidelines,” American Thoracic Society International Conference, San Francisco, CA (May 1997)
Huse D, Klause D, Piercey G, Kuriyama N, Weiss S, Richner R, Hartz S. “Compliance with Inhaled Versus Oral Asthma Medications,” American Thoracic Society International Conference, San Francisco, CA (May 1997)
Oster G, Menzin J, Richner R, Young S, Vera M., Fowler M. “Impact of Carvedilol Therapy for Heart Failure on Costs of Cardiovascular Related Hospitalizations,” American College of Cardiology 46th Annual Scientific Session, Anaheim, CA (Mar 1997)
Huse D, Hartz S, Klaus d, Piercey G, Richner R, Weiss S. “Does Allergic Rhinitis Exacerbate Asthma Symptoms in Adults? The Asthma Outcomes Registry,” European Respiratory Society (ERS) Annual Congress, Stockholm, Sweden (Sep 1996)
Klaus D, Huse D, Richner R, Kuriyama N, Piercey G, Weiss S, Hartz S. “Does Asthma Therapy in Managed Care Conform to Expert Guidelines? The Asthma Outcomes Registry,” International Society for Pharmacoepidemiology Annual Meeting, Amsterdam, Holland (Aug 1996)
Halpern M, Richner R, Togias A, Guo C, de Lissovoy G. “Allergic Rhinitis May Increase Asthma Costs,” American Thoracic Society 1996 International Conference, New Orleans, LA (May 1996)
Huse D, Hartz S, Richner R, Russell M, Piercey G, Weiss S. “Allergic Rhinitis May Worsen Asthma Symptoms in Children: The Asthma Outcomes Registry,” American Thoracic Society 1996 International Conference, New Orleans, LA (May 1996)
Klaus D, Huse D, Hartz S, Richner R, Kuriyama N, Weiss S. “The Prevalence of Sinusitis and Nasal Polyps Among Patients with Asthma in the Asthma Outcomes Registry,” American Thoracic Society 1996 International Conference, New Orleans, LA (May 1996)
Halpern M, Richner R, Togias A, Guo C, de Lissovoy G. ”Incidence of Asthma and Allergic Rhinitis Medical Care Claims in a Large Medical Data Base,” American Thoracic Society 1996 International Conference, New Orleans, LA (May 1996)
Appointed, University of Michigan School of Public Health Dean’s Advisory Board (2006)
Appointed, College of Fellows of the American Institute of Medical and Biological Engineers (2006)
Appointed, Public Affairs Council (PAC) Board of Directors (2005)
Appointed, University of Michigan Ross Business School Healthcare and Life Science Corporate Advisory Board (2005)
Award, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors Service Awards (2003 to 2005)
Appointed, International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors (2003 to 2005)
Appointed, Special Representative to the Board of Advanced Medical Technical Association (AdvaMed) Payment and Policy Committee (2001)
Award, Boston Scientific Hero’s Award (Dec 2000 & 2002)
Founder, US Medical Device Technology Council for ISPOR I (2000)
Appointed, Executive Committee of the Medicare Coverage Advisory Committee (MCAC) by the Secretary of Health and Human Services (HHS) Industry Representative (1999 to 2003)
Appointed, Alumni Board of Governors for the University of Michigan School of Public Health (1998 to 2001)